Skye BioscienceSKYE
13F holders, Q1 2024 (March 31)3holders
$15.63avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Skye Bioscience Inc. (SKYE) in their 13F filings. The largest holders were Versant Venture Management, LLC ($31.4M), Financial Gravity Asset Management, Inc. ($4K) and Tucker Asset Management LLC ($16).
- Company
- Skye Bioscience Inc.
- CUSIP
- 83086J200
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $31.4M |
| Exits | 0 | $0 |
Ownership 3 holders
| Versant Venture Management, LLC | 30.45% | New | 2,007,702 | $31.4M |
| Financial Gravity Asset Management, Inc. | 0.00% | No change | 1,600 | $4K |
| Tucker Asset Management LLC | 0.00% | New | 1 | $16 |
"% of holder's portfolio" is SKYE's weight in each manager's 13F, not the share of Skye Bioscience Inc. the manager owns.